Fig 1.
Metabolic pathway of angiotensinogen.
This figure shows the major metabolites of angiotensinogen, the receptors they act on and the associated enzymes. AT4 is insulin regulated membrane aminopeptidase (IRAP).
Table 1.
Anthropometric and physiologic data of ARDS patients at study entry.
Table 2.
Median RAS peptide concentrations in ARDS patients at study entry.
Table 3.
Median RAS peptide concentrations in ARDS survivors (S) and non-survivors (NS) at 24, 48 and 72 hours.
Table 4.
Median RAS peptide concentrations and ratios between ARDS patients grouped by their renal failure status at study entry.
Table 5.
Comparison of the ratios of circulating RAS peptides in ARDS at study entry.
Table 6.
Multivariate logistic regression model for association with ARDS survival using A(1–9) and A(1–10) in their natural logarithm transformed forms as variables.